“Next generation revolutionary
biopharmaceutical platform company

AbFinder Therapeutics Co., Ltd. is a R&D company of biopharmaceutics based on innovative platform technologies including "PepFc® platform“, which is the one and only small peptide platform technology replacing Fc of IgG, and "AbFinder® platform“, which is a platform technology carrying out from discovering antibody therapeutics to engineering.

“Improving human health by
innovative biopharmaceuticals

Through “Open Innovation” with global biopharmaceutical companies based on our advanced platform technologies, we are tirelessly working to achieve the ultimate goal, improving human health, by developing innovative new drugs.

We will be evolved as a Global No. 1 biopharmaceutical platform company through this effort.